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Abstract
Skin diseases on the external aspect of the ear are seen in a variety of medical disciplines.
Dermatologists, othorhinolaryngologists, general practitioners, general and plastic surgeons are
regularly consulted regarding cutaneous lesions on the ear.
This article will focus on those diseases wherefore surgery or laser therapy is considered as a
possible treatment option or which are potentially subject to surgical evaluation.
Anatomical characteristics
When evaluating skin lesions on the ear, specific anatom-
ical peculiarities should be considered. The outer ear con-
sists of the skin bearing external ear canal and the auricle.
Both are of elastic cartilage covered with skin. It is
attached to the periost and poorly vascularised. The epi-
dermis on the concave aspect lies on a very thin subcutis
which is strongly attached to the auricular cartilage. In
contrast the convex aspect of the outer ear has a thicker
subcutis with a stronger layer of subcutaneous fat which
causes a certain laxity and displaceability compared to the
concave side. An additional anatomical uniqueness is the
high concentration of holocrine ceruminal glands in the
skin of the external ear canal. The cerumen may mask
existing diseases of the skin in the entrance of the external
ear canal. In case of a ceruminal obstruction, an adequate
assessment of the external auditory meatus should be
done only after cleaning, which may demask existing der-
matosis. The auricle is susceptible to environmental influ-
ences and trauma. Because of its exposed localization, the
ear is particularly liable to the effects of ultraviolet (UV)
light and, consequently, to pre-neoplastic and neoplastic
skin lesions. Further, it has a sound-transmitting function
and is located at a visible, esthetically obvious site, draw-
ing considerable attention from the patient. Depending
on the localization, lesions on the external ear which lead
the patient to seek professional help are noticed by the
patient himself or by a relative or friend.
When hidden areas of the outer ear are affected, consulta-
tion may be delayed until very late in the disease process.
This is especially true for malignant tumors which may
often present at an invasive stage, due to the minimal
thickness of the skin compared to other parts of the body.
In many cases, optimal medical care for patients with skin
diseases of the external ear requires an interdisciplinary
approach dermatological, ear-nose-throat and surgical
collaboration. Below, the most important and frequent
skin diseases of the ear which are potentially subject to
surgical or laser therapy are described. Because of the large
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number of different diagnosis a description of all patho-
logic conditions of the external ear seems to be impossi-
ble. Hence, we limited our description to the diseases
which are frequent or call for special attention because of
their prognosis.
Epithelial tumors of the external ear
Non-malignant tumors
Seborrhoic keratosis (Syn.: seborrhoic wart, senile wart, and basal cell 
papilloma)
Seborrhoic keratosis is one of the most common non-
malignant tumor of the external ear. It appears as a light
brown, mostly flat, sometimes exophytic papular lesion
which originates from proliferative epithelial cells (Fig. 1).
Its spread increases with age and can potentially affect the
whole ear, including the external auditory canal [1]. Ultra-
violet light exposure, human papillomavirus infection,
hereditary factors, action of oestrogen and other sex hor-
mones are among those factors which have been sug-
gested in the aetiology of this disease [2]. Secondary
malignant changes may occur but are extremely rare [3].
Although treatment varies from pure trichloroacetic acid,
cryotherapy to electrodessication, we prefer simple curet-
tage or excisional surgery. Since it may be confused with
malignant melanoma or squamous cell carcinoma,
obtaining a specimen for histology is essential. Histologi-
cally this lesion can be devided into seven subtypes: acan-
thotic; hyperkeratotic; adenoidal or reticulated; clonal;
irritated; inverted follicular keratosis; and melanoacan-
thoma variants [3]. Especially irritated types of seborrhoic
keratosis can be misdiagnosed as squamous cell carci-
noma as they frequently show active cellular appearances
and a downward proliferation of the active epithelial cells.
Therefore a sufficient amount of biopsy should be sent for
histologic evaluation in cases of macroscopically suspi-
cious lesions which cannot be clearly evaluated as a com-
mon seborrhoic keratosis.
Atheroma (Syn.: sebaceous cyst, atheroma, steatoma, keratinous 
cyst)
Atheroma is a benign tumor which is mostly located at
the back of the earlobe. On clinical exam, it appears as a 5
– 25 mm firm, displaceable nodule and may show signs
of secondary infection. Sometimes, a pinpoint depression
at the surface of the cyst corresponds to the infundibulum
of a pre-existing hair follicle. The high density of seba-
ceous glands over the earlobe predisposes the ear for this
lesion. Therapy consists of spindle-shaped excision to pre-
vent recurrence. Other techniques of removal include
punch biopsy aspiration followed by curettage and avul-
sion of the cyst wall. Cysts removed from the back of the
ears have the highest recurrence rates (13% and 13.8%)
[4]. Regardless of the chosen treatment, thorough removal
of the cyst wall seems therefore to be essential for reducing
the high recurrence rates.
Granuloma fissuratum (Syn.: acanthoma fissuratum)
Granuloma fissuratum is a reactive process of the skin
usually caused by chronic trauma from ill-fitting eyeglass
frames. The constant pressure of an ill-fitting frame leads
nearly always to an unilateral, skin colored to light red,
tender mass of granulation tissue behind the auricle with
an exophytic, elliptic growth pattern and a central notch
(Fig. 2). Its macroscopic appearance has been compared
to that of a coffee-bean. It should be kept in mind for
resembling malignant tumors. It is a benign differential
diagnosis of basal cell carcinoma or squamos-cell carci-
noma which can often be managed readily with a correc-
Ganuloma Fissuratum Figure 2
Ganuloma Fissuratum. Skin colored to light red, ten-
der mass of granulation tissue behind the auricle with 
an exophytic, elliptic growth pattern and a central 
notch.
Seborrhoic keratosis Figure 1
Seborrhoic keratosis. Brownish, exophytic tumor 
with a velvety to finely verrucous surface. Location 
on the retroauricular site with partial spreading on 
the helical rim.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
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tion of the ill-fitting eyeglass frame [5-7]. A few cases are
reported in the literature, the exact epidemiologic data is
not available as many patients never seek professional
help about it.
Pre-neoplasia
Actinic keratoses (Syn.: solar keratoses or senile keratoses)
Actinic keratoses is a UV light-induced lesion which is
often located on the ear, especially on the helical rim. Its
frequency increases with age and can progress to invasive
squamous cell carcinoma in 20%, a malignant transfor-
mation which treatment can prevent [8]. Its prevalence is
higher in individuals with fair complexion. Mostly, a well-
defined patch with a rough texture, 3–8 mm in diameter,
and typical erythematous base is visible, accompanied by
occasional hyperkeratosis. However the lesion may grow
to large hyperkeratotic plaques with several centimeters in
diameter. Signs of inflammation may occur. In the case of
a persistent, recurrent, or isolated lesion, a biopsy is rec-
ommended to confirm the diagnosis [9]. Effective treat-
ment options are curettage, photodynamic therapy, laser
therapy, topical 5-floururacil (5-FU), diclofenac, colchi-
cine, imiquimod and retinoid application [10-13].
Cutaneous Horn (Syn.: cornu cutaneum)
Cutaneous Horn is not a pathological diagnosis. A variety
of primary underlying processes, benign, premalignant or
malignant, can cause this lesion [14-17]. It presents a
mostly asymptomatic, variably sized, keratotic mass aris-
ing from the superficial layers of the skin or deeply from
the cutis [18]. It generally occurs on sites, which are sub-
jected to actinic radiation, with the upper part of the face
and the ears being the most common area [19]. In a case
series of 643 cutaneous horns, 40% were derived from
malignant or premalignant epidermal lesions (squamos
cell carcinoma, actinic keratosis), and 60% from benign
lesions [17]. The important issue when dealing with this
lesion is accurate determination of the nature of the proc-
esses at its base. An underlying lesion with malignant or
premalignant potential at the base of a cutaneous horn is
a common finding wherefore we recommend excision
and histology.
Malignant tumors
Basal cell carcinoma (Syn,: basalioma, basal cell epitelioma)
Basal cell carcinoma (BCC) accounts for 90% of all
malignant cutaneous lesions in the head and neck region
and is therefore the most common type of skin cancer on
the ear. It makes up one fifth of neoplasms that involve
the ear and the temporal bone [20]. The vast majority of
BCC occurs on the auricular helix and periauricular area
which are especially susceptible as they are exposed to the
most UV light. Nevertheless 15% arise in the external
auditory canal. Five different clinical forms are distin-
guished in the literature: nodular-ulcerative, pigmented,
cystic, superficial multicentric and morphealike. The most
common type is the nodular-ulcerative. The lesion is a
flesh-colored scaling papule, mostly erythematous to
pink, sometimes pigmented, with a surrounding capillary
network. It has a pearly border and can show a central
ulcer (Fig. 3). This most frequent form may infiltrate the
cartilage. Although metastases of BCC are extremely rare,
the invasive character of the tumor can cause extensive
local tissue destruction. The second most common type is
the morphealike or sclerosing subtype. It is more trouble-
some as it has indistinct margins and infiltrates along
deep tissue planes. It spreads centrifugally with a finger-
like growth pattern which complicates therapy. The lesion
can potentially extend to the temporal bone or parotid
gland and remain undetected.
The most successful therapy for basal cell carcinoma is
micrographic-controlled surgery (two stage operation).
Five-year recurrence rates by micrographic-controlled sur-
gery are reported to be between 1 and 5.6% [21,22]. Nev-
ertheless, BCC found in the middle of the face (so-called
H-zone), followed by those on the auricular and preauric-
ular area have the highest rate of recurrence following
treatment by excisional surgery, radiation, cryosurgery,
curettage or electrodessication – all alternative forms of
treatment [23-25]. Several theories attempt to explain the
high rate of relapse. The ear has a complex anatomy which
can confuse the assessment of tumor boundaries [26].
Further an unusual horizontal growth phase makes this
tumor prone to incomplete excision [27]. As mentioned
above, the skin on the concave aspect of the outer ear is
very thin and close to the perichondrium. This encourages
subclinical spread [23] as skin cancers grow both radially
and vertically. Additionally numerous embryonic fusion
planes in the auricular skin have been suggested that may
Basalioma Figure 3
Basalioma. Erythematous papule with indicated 
pearly border. Remark the central ulceration of the 
retroauricular located lesion.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
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contribute to the spread of the tumor [24]. Pensak has
described cartilaginous fissures (Santorini) in the lateral
floor of the ear canal and a bony dehiscence (Huschke's
Foramen) in the medial floor of the ear canal to provide
pathways for intracranial tumor spread which also have to
be considered [28]. In cases of growth into the parotid
gland, a lateral parotidectomy with monitoring of the
facial nerve has to be performed. Closure of skin defects
can be achieved by local flaps in most patients.
Bowens disease (Syn.: Morbus Bowen, carcinoma in situ, squamous 
intraepidermoid neoplasia)
Bowens disease is an intraepidermal carcinoma in situ,
presenting the preinvasive form of squamous cell carci-
noma. It is strongly associated with sun exposure and
lesions are in up to 83% infected with human papilloma-
virus (HPV) type 16 [29]. The lesions are erythematous,
scaly patches or plaques with irregular borders which can
occur anywhere on the skin. They can become hyperkera-
totic, crusted, fissured, or ulcerated and generally occur in
sun-exposed areas. On the ear, they are most frequently
found on the helical rim or the external side of the auricle.
Although the size is variable, Nordin et al. describe a
mean size on the ear of 18 mm (range 5–70 mm) [30].
Bowens disease is a carcinoma in situ of the epidermis and
therefore potentially malignant. Progression to invasive
SCC is noted in approximately 10% of Bowen's lesions. It
should therefore be completely excised when possible by
means of micrographic guided surgery.
Histological the atypical and disordered keratinocytes in
bowens disease extend down the follicular epithelium.
Superficial, topical treatment is therefore associated with
an increased probability of recurrence.
Topical imiquimod, 5-FU, cryotherapy, photodynamic
therapy, x-ray and grenz-ray radiation, cauterization or
diathermy coagulation therapy are described to be effec-
tive but lack mircrographic control [31-33]. The latter
forms of treatment can be considered for large lesions
which are sometimes spread over the whole ear or for
patients who refuse surgery.
Squamous cell carcinoma
Squamous cell carcinoma (SCC) can arise anywhere on
the outer ear and potentially involves the middle ear and
the lateral skull base. Nevertheless the tumor mostly orig-
inates on the helix and anthelix margin where the skin
receives the greatest actinic exposure. Patients are in their
5th to 6th decade of life whereas lesions originating prima-
rily from the external auditory canal generally present 10–
15 years earlier. From all patients with SCC of the head
and neck, 24% involve the ear and the temporal bone.
Sun exposure, fair complexion, cold injury, radiation
exposure and chronic infection as well as an association
with HPV induced viral carcinogenesis are among the pre-
disposing factors [20,34,35]. The tumor is a scaly, indu-
rated, irregular maculopapular lesion which shows an
exo- or endophytic growth pattern with a hyperkeratotic
or ulcerating surface, sometimes accompanied by seroan-
guinous exudates (Fig. 4). When originating from the
external auditory canal hemorrhagic otorrhea, falsely
treated as otitis externa, is common. Suspicion should
arise and biopsy is mandatory whenever otitis externa fails
to respond to adequate conservative therapy.
SCC lesions on the nose and ear have the highest rates of
recurrence which might be due to an association with
embryonic fusion planes [36]. Therapy should therefore
be aggressive as tendency of recurrence is high [37]. A
complete excision by means of micrographic surgery with
tumor free margins is necessary for a successful outcome
Squamous cell carcinoma Figure 4
Squamous cell carcinoma. Exophytic, hyperkeratotic 
tumor with central ulceration, accompanied with 
seroanguinous exudate.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
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and should be attempted whenever possible. Although
this tumor tends to grow in a vertical fashion it is less
likely to respect the barriers of cartilage and bone than
BCC. Consequently intratemporal spread with involve-
ment of the external auditory canal is possible and can
lead to conductive hearing loss. With further deep exten-
sion facial nerve palsy due to destruction of the facial
nerve along its vertical or tympanic segment may evolve,
and finally a further advancement into the internal audi-
tory canal and cerebellopontine angle may cause dizziness
and/or sensorineural hearing loss.
Additionally it is important to investigate for possible
regional lymph node metastases which portends poor
prognosis. Locoregional metastases follow the lymphatic
drainage patterns which include the parotid and upper
cervical nodes [38,39]. Nodal involvement is reported to
be present in 1–12.5% of all cases [40-42]. Therapy for
locoregional metastases is regional lymphadenectomy
(Neck-dissection level I-V), followed by postoperative
irradiation. It has been suggested that with evidence of
lymphovascular or perineural spread in the primary spec-
imen the nearest "sentinel node" should be examined. In
cases of histologically aggressive malignancy prophylactic
lymphadenectomy and/or regional irradiation should be
considered [43,44]. However large multi-institutional
studies are missing, therefore the role of sentinel lymph
node biopsy for SCC of the head and face region can not
be determined so far.
Non-epithelial tumors of the external ear
Non-malignant tumors
Keloid
Keloid  is first described in the Smith Papyrus from
ancient Egypt [45]. It is derived from the word cheloide
which was in the modern languages first mentioned by
the French physician Noël Retz in 1790 and later
described by Jean Louis Alibert in 1816 [46,47]. It is com-
posed of the Greek words chele (ηλη), meaning crab's
claw, and the suffix -oid, meaning like. Keloids are dermal
fibrotic lesions which are considered an aberration of the
wound healing process. They are included in the spectrum
of fibroproliferative disorders and commonly affect the
ears. Clinically dense dermal scar tissue projects above the
surrounding skin which is sometimes tender or pruritic
(Fig. 5). Keloids on the ear can sometimes be peduncu-
lated. Histology shows thick hyalinized collagen bundles,
abundant ground substance, few fibroblasts, and few if
any foreign body reactions. They are common after small
skin excisions, ear piercing, drainage of auricular hemato-
mas, repair of other auricular traumas, viral infection
(smallpox, and herpes varicella-zoster) or as secondary
keloid formation after prior keloid excision. In a review of
1200 pierced ears, Simplot et al. report a keloid formation
in 2.5% [48]. Several procedures have been described for
effective treatment of post-surgical keloid scars. They
include silicon occlusive dressings, mechanical compres-
sion, radiation, cryosurgery, topical Imiquimod applica-
tion, bleomycin tattooing, intralesional injections of
steroids, 5-floururacil, as well as interferon-alpha, -beta or
-gamma in combination with excisional surgery [49-55].
Although optimal conditions for the prevention of keloid
formation are still unknown the combination of exci-
sional surgery and the placement of a silicone gel sheet
over the wound surface with the application of light pres-
sure are known to be advantageous [56-58].
Pre-neoplasia
Lentigo maligna (Syn.: Hutchinson's freckle)
Lentigo maligna (LM) is a slow-growing, non-invasive
melanoma in situ. Little attention is paid to this insidious
lesion which can potentially become an invasive lentigo
maligna melanoma with a conversion rate of 33–50%
[59]. The estimated lifetime risk of LM progressing to LM
melanoma is 5% [60]. The lesion begins as an unevenly
pigmented and irregularly bordered, brown to black mac-
ule which slowly extends in the course of time. The lesions
size can sometimes obtain several centimetres. It begins as
a tan macule which extends peripherally within the course
of several years. Non-surgical therapy such as cryosurgery,
radiotherapy, electrodessication and curettage, laser sur-
gery, and topical medications with a recurrence rate rang-
ing from 20 to 100% at 5 years have been described in the
literature. Recurrence following standard therapies is
common because histologic evaluation can be difficult
due to the widespread atypical melanocytes that are
present in the background of long-standing sun damage
[59]. Whenever excision by means of micrographic-con-
trolled or MOHS surgery is possible it should be the pre-
ferred method of treatment as it shows the lowest
Keloid Figure 5
Keloid. Flesh colored to reddish to slight purple nod-
ule on the helical rim. The exophytic tumor shows a 
smooth surface.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
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recurrence rate (4–5%) and the best form of margin con-
trol among all described forms of therapy. As this lesion
occurs more frequently in an elderly patient population,
alternative forms of treatment, such as radiotherapy, have
to be considered when patients present with very large
lesions that are not subject to reconstructive surgery.
Malignant tumours
Melanoma (Syn.: malignant melanoma)
Approximately twenty percent of all primary melanomas
are located at the head and neck, of which 7–14% are
located at the ear's helix and antihelix. Peripheral parts of
the ear are more frequently affected. Interestingly the left
ear is more often affected than the right ear. The most
accepted theory for this phenomenon is the asymetric UV-
dosage in anglo-saxon countries with left-hand driven
cars. Further, a male predisposition of 61.5–90.5% is
reported in the literature with a predisposition for fair-
skinned individuals [61-66]. It can be explained with dif-
ferent hair styles which correlate with UV exposition. With
the exception of young children this disease affects all age
groups. The average age is 50 years.
The patients report an asymmetric flat hyperpigmentation
or a raised nodular lesion which has changed in color and
size. Amelanotic (non-pigmented) variants exist as well.
The three most described subtypes are the superficial
spreading melanoma, the nodular melanoma and the len-
tigno maligna melanoma. Each type has its characteristic
growth pattern with a horizontal and a vertical growth
phase. All over the body, the superficial spreading
melanoma is the most common type (Fig. 6). It shows an
intermediate radial growth phase before starting to invade
the dermis.
A prolonged radial growth phase is characteristic for Len-
tigo maligna melanoma. A study by Koh et al showed that
8.3% of all head and neck lentigo maligna melanomas
occur on the ear [67]. It begins as a macular lesion with a
variable pigmentation with an uneven irregular border
which shows a sudden increase in size, induration and
darkening of the lesion (Fig. 7). The most aggressive
melanoma type is the nodular variant, which is a rapidly
growing dark pigmented nodule which invades the der-
mis early in the disease course. The thin layer of subcuta-
neous tissue contributes to the distinctive invasiveness
and therefore bad prognosis for melanoma on the ear. Key
pathologic prognostic features of auricular melanomas
include the histological subtype, tumor thickness, level of
invasion and presence of ulceration. Jahn et al. showed
that age, locality, tumour thickness, histological type,
level of invasion and excision margins to be significant
risk factors for local recurrence [68]. Nevertheless the
overall survival of patients with melanoma on the ear
depended only on the tumour thickness and Clark level of
invasion. Therapy is a surgical approach and in some
instances adjuvant therapy. Recommended excision mar-
gins are 10–20 mm for primary nodular melanoma (NM)
or superficial spreading melanoma (SSM) and 5 mm with
complete threedimensional histology of excision margins
(3D histology) for lentigo maligna melanoma (LMM).
The World Health Association requires a safety margin of
5 mm for melanoma in situ and 20 mm for melanoma
which are >2.1 mm in vertical thickness. Recent studies
have shown that margins > 10 mm have the lowest risk of
recurrence [68]. In recent years the more aggressive surgi-
cal approach has changed towards narrower excision mar-
gins as it has been shown to have only an effect on the
incidence of local recurrence and only little impact on dis-
ease specific survival.
The available data for sentinel node sampling do not per-
mit definitive conclusions regarding a prognostic or even
Superficial spreading melanoma Figure 6
Superficial spreading melanoma. Dark and flat mac-
ule with variegated colors. Its borders are irregular, 
with indentations and notches.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
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therapeutic impact of sentinel lymph node biopsy (SLNB)
in patients with melanoma of the ear. Patients with
tumours thicker than 1 mm are currently undergoing
SLNB and should be included in large multicenter studies.
In special cases where surgical removal of a lentigo
maligna melanoma is not possible, radiation therapy
should be considered as an alternative with good results
[69]. Unfortunately this tumor is aggressive, with a ten-
dency for spreading to both regional lymph nodes and
distant sites. One third of all patients presenting with
auricular melanoma have cervical lymph node involve-
ment. As the correlation between melanoma location and
drainage is inconsistent lymphoscintigraphy with sentinel
node sampling seems to be the primary method of identi-
fying nodal disease [70,71]. However a final evaluation is
not possible. Adjuvant therapy includes chemotherapy,
immunotherapy, and radiation.
Inflammatory lesions
Winkler Disease (Syn.: Chondrodermatitis Nodularis Chronica 
Helicis)
Winkler Disease is a chronic perichondritis which is
thought to be related to limited vascularity at the lateral
and anterior aspect of the auricle. The skin is tightly
stretched over the underlying cartilage with minimal sub-
cutaneous tissue which results in limited vascularity and
ischaemia which is thought to promote the development
of this lesion [72]. Mostly located on the helix this disease
is characterized by a hard nodule which involves the skin
and the cartilage of the ear (Fig. 8). Patients present with
severe pain in the affected ear especially when slept on it
at night. Although conservative treatment (radiation, top-
ical antibiotics, intralesional steroids) has been described
Winkler disease Figure 8
Winkler disease. Ulcerated nodule with overlying 
crust. The surrounding skin is inflamed as indicated 
by the red color. Remark: If painful ulcerated nodules 
are present at the external ear, Winkler disease has 
to be kept in mind.
Lentigo maligna melanoma Figure 7
Lentigo maligna melanoma. Irregular pigmented and 
bordered, brown to black macule with visible bright 
to reddish regression zone.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
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s
urgical excision should be preferred as lesions show a ten-
dency to recur. A minimal skin excision should be com-
bined with a more extensive cartilage resection to avoid
recurrence [73].
Lymphocytoma (Syn.: Lymphadenosis cutis benigna)
Lymphocytoma can be an early manifestation of an infec-
tion with Borellia burgdorferi causing Lyme disease. Ini-
tially it causes a characteristic rash, erythema chronicum
migrans, which is located at the tic bite area. During the
second stage an intensely red-violet swelling of the ear-
lobe is characteristic (Fig. 9). An infection with Borellia
burgdorferi is the case in one third of all earlobe lym-
phocytomas wherefore is has to be ruled out serologically
when suspected. The majority (two third of all cases) are
idiopathic. Antibiotic therapy consists of doxycyclin p.o.
for 2–3 weeks. When the lesions do not improve under
Cutaneous tuberculosis Figure 11
Cutaneous tuberculosis. Retroauricular located red, 
partially brownish plaque with smooth surface.
Lymphocytoma Figure 9
Lymphocytoma. Visible intensely red-violet swelling 
of the right earlobe.
Polychondritis recidivans Figure 10
Polychondritis recidivans. Visible deformity of the 
ears cartilage, resulting from recurrent chondritis.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
Page 9 of 13
(page number not for citation purposes)
antibiotic treatment pseudolymphoma is one possible
differential diagnosis. Small lesions can be excised.
Infectious lesions
Infectious lesions of the external ear are rarely subject to
surgical intervention. Nevertheless drainage of the sub-
perichondral space and surgical removal of necrotic ear
tissue following infectious diseases of the external ear are
sometimes necessary.
Auricular chondritis and perichondritis is an infection
of the auricle. Clinically the ear appears erythematous,
tender and a fluctuant swelling is mostly present. Typi-
cally an inciting event (piercing, surgery, trauma, wres-
tling, acupuncture) is followed by an infection resulting
from the collection of blood or serum in the subperichon-
drial space [74]. The most common organisms which
have been tested as causative are S. aureus, P. aeruginosa
and Proteus species [75]. The subperichondral space must
be surgically evacuated and antibiotic therapy consisting
of an antipseudomonal aminopenicillin or a flourqui-
nolone for a period of 2–4 weeks, applied [76]. As a result
of recurring chondritis persisting deformities of the ears'
cartilage can remain (Fig. 10).
Lupus vulgaris is a persistent form of cutaneous tubercu-
losis which potentially involves the ear. Lesions are
sharply defined and brown, with a gelatinous consistency
on erythematous base (Fig. 11). Therapy is a combination
of antibiotics (isoniazid, rifampicin, pyrazinamide and
ethambutol) given over a period of several months, and
Multiple blue naevus: Multiple, gray to blue, pinhead-sized  macules affecting the external ear Figure 13
Multiple blue naevus: Multiple, gray to blue, pinhead-
sized macules affecting the external ear. If multiple 
blue naevi appear at the head and neck, remind that 
rare syndromes (e.g. Carney's syndrome) may be 
causal.
Cylindroma Figure 12
Cylindroma. Numerous pink, red, and partially blu-
ish, firm nodules, affecting the upper parts of the ear 
and spreading to the left cheek. The distribution and 
arrangement of tumor masses resemble a bunch of 
grapes.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
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surgical excision of necrotic tissue. As tuberculosis is
enjoying a renaissance in western countries the incidence
of cutaneous tuberculosis will increase in the future.
Rare Lesions
Cylindroma (Syn.: Cylindroma, Spiegler's Tumor, Turban Tumor)
Cylindroma is benign, solitary or group-like skin colored
or light red, bulging, protuberand tumors with a flat, shin-
ing surface. They are usually located at the head and neck
(turban tumor) and can potentially involve the ear (Fig.
12). They most likely represent very primitive sweat gland
tumors originating from eccrine or apocrine glands. His-
tologically they show apocrine, eccrine, secretory, and
ductal features, and the exact cellular origin of cylindro-
mas remains unknown. Although benign, malignant
transformation (cylindrocarcinoma) has been reported,
in which case surgical excision is the treatment of choice
[77].
Adnexal Tumours (Syn.: Sweat gland tumours)
As the skin of the external auditory canal shows a high
concentration of ceruminal glands it is susceptible for this
already very rare type of benign and malignant tumours.
Benign adnexal tumours include ceruminous adenomas
and pleomorphic adenoma which are best treated by wide
local excision [78]. Malignant adnexal tumours include
adenoidcystic-, mucinous-, cylindro-, poro-, spiradeno
and adenocarcinoma [79-81]. They should be treated by
an initial aggressive wide en bloc surgical resection with a
primary lateral or subtotal temporal bone resection stage
dependent combined with a parotidectomy and neck dis-
section. Even in T1 tumours local resection is described to
be not sufficient [82]. However due to their rarity, a fur-
Osler-Weber-Rendu Disease Figure 15
Osler-Weber-Rendu Disease. Multiple, punctuate, 
red macules and papules corresponding to hemangi-
omas and telangiectases.
Auricular appandage: Dome-shaped, flesh-colored nodule  with smooth surface at the upper part of the tragus Figure 14
Auricular appandage: Dome-shaped, flesh-colored 
nodule with smooth surface at the upper part of the 
tragus.Head & Face Medicine 2008, 4:2 http://www.head-face-med.com/content/4/1/2
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ther discussion of these individual tumors is beyond the
scope of this article.
Blue Nevus (Syn.: Naevus bleu, Tieche's Nevus)
The blue nevus is a variant of a common benign mole
which can be clinically misdiagnosed as a melanoma. The
lesion is a gray blue to dark blue, smooth surfaced macule
which is composed of melanocytes. When multiple blue
nevi are located at the head and neck Carney's syndrome,
a rare association of blue nevi with hypercortisolism and
a variety of nonendocrine (myxomas) and endocrine
tumors should be considered (Fig. 13). Solitary, stable
lesions can be observed. A changing pigmented lesion
should be biopsied to rule out the differential diagnosis of
a malignant melanoma.
Auricular appendages are themselves harmless lesions
(Fig. 14). In very rare cases they can be cutaneous manifes-
tation of a complex disease. Goldenhar syndrome,
Wildervanck syndrome, and VACTERL association are
very rare diseases which should be considered further.
Surgical therapy is only done according to a specific wish
of the patient.
Osler-Weber-Rendu Disease (Hereditary hemorrhagic
teleangiectasia) is an autosomal dominant disease which
manifests itself with multiple punctuate hemangiomas
and telangiectases (Fig. 15). Additional characteristics are
epistaxis and mucocutaneous visceral arteriovenous mal-
formations. Laser therapy with a long-pulsed Nd:YAG
laser, flash-pumped dye laser, or an intense pulsed light
(IPL) system has been described as effective.
Conclusion
The outer ear with the auricle and ear canal can be affected
by a variety of different skin lesions and dermatologic
conditions. They can be either solitary lesions which are
locally limited to the ear or are part of a generalized der-
matologic condition. They can afflict skin, cartilage,
glands, vessels and hair follicles of the outer ear.
The outer ear itself plays a functional role in audition by
collecting and transmitting sound. Additionally it has an
important effect on facial appearance and therefore on the
individual psychological disposition. Although the auri-
cles skin macroscopically shares the anatomy and physiol-
ogy of the bodys skin it shows some histological
differences compared to the rest of the bodys skin. This
specific anatomical peculiarities should be considered
when treating skin lesions on the ear.
In cloncusion, the authors suggest that an interdiscipli-
nary approach that combines surgery, dermatology and
otolaryngology can provide optimal care for the patient.
The most common skin diseases of the outer ear which are
potentially subject of surgical or laser therapy have been
described briefly in this review.
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